Elite Health Systems Inc.
Income Statement
| Line Item | Aug 2026 | Jun 2026 | Apr 2026 | Apr 2026 | Mar 2026 | Dec 2025 | Oct 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $1.3M | — | — | $1.4M | — | — | $0 |
| Cost of Revenue | — | $1.1M | — | — | $1.3M | — | — | — |
| Gross Profit | — | $168.0K | — | — | $117.0K | — | — | — |
| Gross Margin | — | 12.8% | — | — | 8.4% | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | — | $1.7M | — | — | $1.4M | — | — | $1.2M |
| Operating Income | — | $-1.5M | — | — | $-1.3M | — | — | $-1.2M |
| Operating Margin | — | -117.6% | — | — | -92.8% | — | — | — |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | — | — | — | — | — | — | $-1.2M |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | — | $-1.5M | — | — | $-1.3M | — | — | $-1.2M |
| Net Margin | — | -116.9% | — | — | -92.6% | — | — | — |
| EPS (Basic) | — | $-0.05 | — | — | $-0.05 | — | — | $-0.05 |
| EPS (Diluted) | — | — | — | — | — | — | — | — |
| Shares Outstanding (Basic) | 28.5M | 28.5M | 28.5M | 28.5M | 28.5M | 28.5M | 21.9M | 21.7M |
| Shares Outstanding (Diluted) | 28.5M | 28.5M | 28.5M | 28.5M | 28.5M | 28.5M | 21.9M | 21.7M |
| Dividends Per Share | — | — | — | — | — | — | — | — |